PBYI EPS Growth
Period ending:
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
PBYI eps growth history
Year-over-year earnings per share growth rate. The available trailing twelve months (ttm) series contains 68 observations from Sep 30, 2009 to Jun 30, 2026.
| Period ending | EPS Growth |
|---|---|
| -45.2857% | |
| -35.2388% | |
| 3.909% | |
| 57.4638% | |
| 426.0333% | |
| 135.3194% | |
| 33.1065% | |
| 530.8609% | |
| 455.5344% | |
| 190.455% | |
| 30,266.6667% | |
| -65.9142% | |
| 93.9112% | |
| 109.337% | |
| 100.2113% | |
| 118.6134% | |
| 3.3034% | |
| -79.194% | |
| 52.9801% | |
| 16.1972% | |
| 16.0377% | |
| 68.3962% | |
| 22.5641% | |
| 42.2764% | |
| 55.8333% | |
| 18.4615% | |
| 34.7826% | |
| 36.9231% | |
| 57.1429% | |
| 60.1838% | |
| 61.9108% | |
| 52.3227% | |
| 31.1193% | |
| 19.1832% | |
| 5.4217% | |
| -0.2451% | |
| -1.4981% | |
| -1.3802% | |
| -11.5591% | |
| -14.7679% | |
| -24.5723% | |
| -39.5797% | |
| -57.6271% | |
| -92.1622% | |
| -113.6213% | |
| -164.3519% | |
| -148.4211% | |
| -69.7248% | |
| -1.3468% | |
| 33.945% | |
| 44.9275% | |
| 30.3514% | |
| -61.3078% | |
| -196.7332% | |
| -571.5982% | |
| -55,792.8571% | |
| -33,376.3636% | |
| -19,936.3636% | |
| -9,412.963% | |
| -21.7391% | |
| -19.5652% | |
| -5.7692% | |
| 3.5714% | |
| 11.5385% | |
| 14.8148% | |
| -1.9608% | |
| -21.7391% | |
| 99.8967% |
Compare eps growth
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Brightspring Health Services Inc (BTSG) eps growth
- Ensign Group Inc (ENSG) eps growth
- Krystal Biotech Inc (KRYS) eps growth
- Protagonist Therapeutics Inc (PTGX) eps growth
- Tg Therapeutics Inc (TGTX) eps growth
- Healthequity Inc (HQY) eps growth
- Pacs Group Inc (PACS) eps growth
- Alkermes (ALKS) eps growth
Compare all covered stocks by eps growth →
All PBYI financial metrics · PBYI stock overview · How to interpret financial metrics